Skip to main content

Advertisement

Figure 1 | EJNMMI Research

Figure 1

From: Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors

Figure 1

SUV ratios of target lesions to normal tissue in pre- and intra-therapeutic settings using 68 Ga-DOTATOC PET. The images show the comparison of the mean tumor-to-liver (A) and tumor-to-spleen (B) SUV ratios in each patient (n = 5).

Back to article page